Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Tyring

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
JAMA|December 21, 2016
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical TrialAnna Wald, Burkhard Timmler, Amalia Magaret, et al.
Journal of the American Academy of Dermatology|August 11, 2019
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR studyDiamant Thaçi, Lluís Puig, Kristian Reich, et al.
Journal of Dermatological Science|January 23, 2023
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S studyAndrew Blauvelt, David M Pariser, Stephen Tyring, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 12, 2001
Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerismJianchao Zong, Dolores M Ciufo, Raphael Viscidi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2004
Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutationsHeidi Erlandsen, Angel L Pey, Alejandra Gámez, et al.
Clinical and Experimental Dermatology|May 3, 2024
Cedirogant in adults with psoriasis: a phase II, randomized, placebo-controlled clinical trialStephen Tyring, Angela Moore, Akimchi Morita, et al.
The Journal of Dermatological Treatment|August 9, 2021
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysisKim Papp, Zygmunt Adamski, Lyn Guenther, et al.
Archives of Dermatology|September 21, 2011
Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterizationRachael L Moore, Virginie de Schaetzen, Marissa Joseph, et al.
Journal of the American Academy of Dermatology|February 23, 2016
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension studyKim A Papp, James G Krueger, Steven R Feldman, et al.
The New England Journal of Medicine|January 17, 2014
Helicase-primase inhibitor pritelivir for HSV-2 infectionAnna Wald, Lawrence Corey, Burkhard Timmler, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
JAMA|December 21, 2016
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical TrialAnna Wald, Burkhard Timmler, Amalia Magaret, et al.
Journal of the American Academy of Dermatology|August 11, 2019
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment: Results from the CLEAR studyDiamant Thaçi, Lluís Puig, Kristian Reich, et al.
Journal of Dermatological Science|January 23, 2023
Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S studyAndrew Blauvelt, David M Pariser, Stephen Tyring, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 12, 2001
Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerismJianchao Zong, Dolores M Ciufo, Raphael Viscidi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2004
Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutationsHeidi Erlandsen, Angel L Pey, Alejandra Gámez, et al.
Clinical and Experimental Dermatology|May 3, 2024
Cedirogant in adults with psoriasis: a phase II, randomized, placebo-controlled clinical trialStephen Tyring, Angela Moore, Akimchi Morita, et al.
The Journal of Dermatological Treatment|August 9, 2021
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysisKim Papp, Zygmunt Adamski, Lyn Guenther, et al.
Archives of Dermatology|September 21, 2011
Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterizationRachael L Moore, Virginie de Schaetzen, Marissa Joseph, et al.
Journal of the American Academy of Dermatology|February 23, 2016
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension studyKim A Papp, James G Krueger, Steven R Feldman, et al.
The New England Journal of Medicine|January 17, 2014
Helicase-primase inhibitor pritelivir for HSV-2 infectionAnna Wald, Lawrence Corey, Burkhard Timmler, et al.
Pageof 13